REQUEST A DEMO
Total
USD $0.00
FAQ
Secure shopping

Healthcare and pharma

The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.

The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.

2 3 4 5 6 18
China Pharmaceutical Sector Report 2024 Q3 - Page 1
China Pharmaceutical Sector Report 2024 Q3 EMIS Insights Industry Reports

According to Deloitte, China has been the second largest pharmaceutical market after the US since 2017 and had a market share of 11% in the global pharmaceutical market by the end of 2022. According to the National Bureau of Statistics (NBS), the ...

View more details
USD 995 Date: November 2024 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2024 Q3 - Page 1
China Healthcare Sector Report 2024 Q3 EMIS Insights Industry Reports

China's healthcare system is hospital-centric, and most of the inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. On the other hand, due to the growing demand for specialised healthcare and ...

View more details
USD 995 Date: October 2024 Language: English
Format: PDF
Add to basket
China Pharmaceutical Sector Report 2024 Q2 - Page 1
China Pharmaceutical Sector Report 2024 Q2 EMIS Insights Industry Reports

According to Deloitte, China has been the second largest pharmaceutical market after the US since 2017 and had a market share of 11% in the global pharmaceutical market by the end of 2022. According to the National Bureau of Statistics (NBS), the ...

View more details
USD 995 Date: August 2024 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2024 Q2 - Page 1
China Healthcare Sector Report 2024 Q2 EMIS Insights Industry Reports

China's healthcare system is hospital-centric, and most of the inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. On the other hand, due to the growing demand for specialised healthcare and ...

View more details
USD 995 Date: August 2024 Language: English
Format: PDF
Add to basket
CEE Pharma and Healthcare Sector Report 2024-2025 - Page 1
CEE Pharma and Healthcare Sector Report 2024-2025 EMIS Insights Industry Reports

Poland's healthcare and pharmaceutical industry is making significant strides, despite facing substantial challenges. The ongoing war in Ukraine, which followed the COVID-19 pandemic, has placed considerable pressure on the Polish healthcare system. ...

View more details
USD 995 Date: August 2024 Language: English
Format: PDF
Add to basket
Indian Pharma and Healthcare H2 FY2024 Half-Annual Update - Page 1
Indian Pharma and Healthcare H2 FY2024 Half-Annual Update EMIS Insights Industry Reports

The Indian pharmaceuticals and healthcare sector is experiencing an increase in activity. India's robust economic growth and the increased health awareness post-pandemic drive more patients and their families to private healthcare service providers. ...

View more details
USD 995 Date: August 2024 Language: English
Format: PDF
Add to basket
China Healthcare Sector Report 2024 1st Quarter - Page 1
China Healthcare Sector Report 2024 1st Quarter EMIS Insights Industry Reports

China's healthcare system is hospital-centric, and most of the inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. On the other hand, due to the growing demand for specialised healthcare and ...

View more details
USD 995 Date: July 2024 Language: English
Format: PDF
Add to basket
China Pharmaceutical Sector Report 2024 1st Quarter - Page 1
China Pharmaceutical Sector Report 2024 1st Quarter EMIS Insights Industry Reports

According to Deloitte, China has been the second largest pharmaceutical market after the US since 2017 and had a market share of 11% in the global pharmaceutical market by the end of 2022. According to the National Bureau of Statistics (NBS), the ...

View more details
USD 995 Date: July 2024 Language: English
Format: PDF
Add to basket
Poland Pharma and Healthcare Sector Report 2024-2025 - Page 1
Poland Pharma and Healthcare Sector Report 2024-2025 EMIS Insights Industry Reports

Poland's healthcare and pharmaceutical industry is making significant strides, despite facing substantial challenges. The ongoing war in Ukraine, which followed the COVID-19 pandemic, has placed considerable pressure on the Polish healthcare system. ...

View more details
USD 995 Date: July 2024 Language: English
Format: PDF
Add to basket
India Pharma and Healthcare Sector Report 2024-2025 - Page 1
India Pharma and Healthcare Sector Report 2024-2025 EMIS Insights Industry Reports

India's pharmaceutical and healthcare sector is world-renowned. India is known as the "pharmacy of the world" due to its prolific output of generic medicines and vaccines; in particular, the Indian vaccine producer, Serum Institute of India, played a ...

View more details
USD 995 Date: June 2024 Language: English
Format: PDF
Add to basket
2 3 4 5 6 18